Magnetic resonance imaging of the substantia nigra in Parkinson's disease.
Identifieur interne : 000D48 ( PubMed/Checkpoint ); précédent : 000D47; suivant : 000D49Magnetic resonance imaging of the substantia nigra in Parkinson's disease.
Auteurs : Stéphane Lehéricy [France] ; Michael A. Sharman ; Clarisse Longo Dos Santos ; Raphaël Paquin ; Cecile GalleaSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2012.
English descriptors
- KwdEn :
- MESH :
Abstract
Until recently, conventional magnetic resonance imaging (MRI) was most often negative in Parkinson's disease or showed nonspecific findings. Recent developments in structural MRI, including relaxometry, magnetization transfer, and neuromelanin imaging, have demonstrated improved contrast and enabled more accurate visualization of deep brain nuclei, in particular, the substantia nigra. Meanwhile, diffusion imaging has provided useful biomarkers of substantia nigra degeneration, showing reduced anisotropy and anatomical connectivity with the striatum and thalamus. These advances in structural imaging are complemented by findings of magnetic resonance spectroscopy on brain metabolism and resting-state functional MRI on functional connectivity. This article presents an overview of these new structural, metabolic, and resting-state functional MRI techniques and their implications for Parkinson's disease. The techniques are reviewed in the context of their potential for better understanding the disease in terms of diagnosis and pathophysiology and as biomarkers of its progression.
DOI: 10.1002/mds.25015
PubMed: 22649063
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22649063Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Magnetic resonance imaging of the substantia nigra in Parkinson's disease.</title>
<author><name sortKey="Lehericy, Stephane" sort="Lehericy, Stephane" uniqKey="Lehericy S" first="Stéphane" last="Lehéricy">Stéphane Lehéricy</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre de NeuroImagerie de Recherche-CENIR, Groupe Hospitalier Pitie-Salpetriere, Paris, France. stephane.lehericy@upmc.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de NeuroImagerie de Recherche-CENIR, Groupe Hospitalier Pitie-Salpetriere, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sharman, Michael A" sort="Sharman, Michael A" uniqKey="Sharman M" first="Michael A" last="Sharman">Michael A. Sharman</name>
</author>
<author><name sortKey="Dos Santos, Clarisse Longo" sort="Dos Santos, Clarisse Longo" uniqKey="Dos Santos C" first="Clarisse Longo" last="Dos Santos">Clarisse Longo Dos Santos</name>
</author>
<author><name sortKey="Paquin, Raphael" sort="Paquin, Raphael" uniqKey="Paquin R" first="Raphaël" last="Paquin">Raphaël Paquin</name>
</author>
<author><name sortKey="Gallea, Cecile" sort="Gallea, Cecile" uniqKey="Gallea C" first="Cecile" last="Gallea">Cecile Gallea</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1002/mds.25015</idno>
<idno type="RBID">pubmed:22649063</idno>
<idno type="pmid">22649063</idno>
<idno type="wicri:Area/PubMed/Corpus">000D61</idno>
<idno type="wicri:Area/PubMed/Curation">000D61</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D48</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Magnetic resonance imaging of the substantia nigra in Parkinson's disease.</title>
<author><name sortKey="Lehericy, Stephane" sort="Lehericy, Stephane" uniqKey="Lehericy S" first="Stéphane" last="Lehéricy">Stéphane Lehéricy</name>
<affiliation wicri:level="1"><nlm:affiliation>Centre de NeuroImagerie de Recherche-CENIR, Groupe Hospitalier Pitie-Salpetriere, Paris, France. stephane.lehericy@upmc.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre de NeuroImagerie de Recherche-CENIR, Groupe Hospitalier Pitie-Salpetriere, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sharman, Michael A" sort="Sharman, Michael A" uniqKey="Sharman M" first="Michael A" last="Sharman">Michael A. Sharman</name>
</author>
<author><name sortKey="Dos Santos, Clarisse Longo" sort="Dos Santos, Clarisse Longo" uniqKey="Dos Santos C" first="Clarisse Longo" last="Dos Santos">Clarisse Longo Dos Santos</name>
</author>
<author><name sortKey="Paquin, Raphael" sort="Paquin, Raphael" uniqKey="Paquin R" first="Raphaël" last="Paquin">Raphaël Paquin</name>
</author>
<author><name sortKey="Gallea, Cecile" sort="Gallea, Cecile" uniqKey="Gallea C" first="Cecile" last="Gallea">Cecile Gallea</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Magnetic Resonance Imaging</term>
<term>Parkinson Disease (pathology)</term>
<term>Relaxation</term>
<term>Substantia Nigra (pathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Magnetic Resonance Imaging</term>
<term>Relaxation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Until recently, conventional magnetic resonance imaging (MRI) was most often negative in Parkinson's disease or showed nonspecific findings. Recent developments in structural MRI, including relaxometry, magnetization transfer, and neuromelanin imaging, have demonstrated improved contrast and enabled more accurate visualization of deep brain nuclei, in particular, the substantia nigra. Meanwhile, diffusion imaging has provided useful biomarkers of substantia nigra degeneration, showing reduced anisotropy and anatomical connectivity with the striatum and thalamus. These advances in structural imaging are complemented by findings of magnetic resonance spectroscopy on brain metabolism and resting-state functional MRI on functional connectivity. This article presents an overview of these new structural, metabolic, and resting-state functional MRI techniques and their implications for Parkinson's disease. The techniques are reviewed in the context of their potential for better understanding the disease in terms of diagnosis and pathophysiology and as biomarkers of its progression.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22649063</PMID>
<DateCreated><Year>2012</Year>
<Month>06</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>11</Month>
<Day>13</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>7</Issue>
<PubDate><Year>2012</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Magnetic resonance imaging of the substantia nigra in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>822-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25015</ELocationID>
<Abstract><AbstractText>Until recently, conventional magnetic resonance imaging (MRI) was most often negative in Parkinson's disease or showed nonspecific findings. Recent developments in structural MRI, including relaxometry, magnetization transfer, and neuromelanin imaging, have demonstrated improved contrast and enabled more accurate visualization of deep brain nuclei, in particular, the substantia nigra. Meanwhile, diffusion imaging has provided useful biomarkers of substantia nigra degeneration, showing reduced anisotropy and anatomical connectivity with the striatum and thalamus. These advances in structural imaging are complemented by findings of magnetic resonance spectroscopy on brain metabolism and resting-state functional MRI on functional connectivity. This article presents an overview of these new structural, metabolic, and resting-state functional MRI techniques and their implications for Parkinson's disease. The techniques are reviewed in the context of their potential for better understanding the disease in terms of diagnosis and pathophysiology and as biomarkers of its progression.</AbstractText>
<CopyrightInformation>Copyright © 2012 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehéricy</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Centre de NeuroImagerie de Recherche-CENIR, Groupe Hospitalier Pitie-Salpetriere, Paris, France. stephane.lehericy@upmc.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sharman</LastName>
<ForeName>Michael A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dos Santos</LastName>
<ForeName>Clarisse Longo</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Paquin</LastName>
<ForeName>Raphaël</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gallea</LastName>
<ForeName>Cecile</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>05</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007091">Image Processing, Computer-Assisted</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008279">Magnetic Resonance Imaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012063">Relaxation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013378">Substantia Nigra</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>1</Month>
<Day>7</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2012</Year>
<Month>3</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>3</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2012</Year>
<Month>5</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>11</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.25015</ArticleId>
<ArticleId IdType="pubmed">22649063</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Dos Santos, Clarisse Longo" sort="Dos Santos, Clarisse Longo" uniqKey="Dos Santos C" first="Clarisse Longo" last="Dos Santos">Clarisse Longo Dos Santos</name>
<name sortKey="Gallea, Cecile" sort="Gallea, Cecile" uniqKey="Gallea C" first="Cecile" last="Gallea">Cecile Gallea</name>
<name sortKey="Paquin, Raphael" sort="Paquin, Raphael" uniqKey="Paquin R" first="Raphaël" last="Paquin">Raphaël Paquin</name>
<name sortKey="Sharman, Michael A" sort="Sharman, Michael A" uniqKey="Sharman M" first="Michael A" last="Sharman">Michael A. Sharman</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Lehericy, Stephane" sort="Lehericy, Stephane" uniqKey="Lehericy S" first="Stéphane" last="Lehéricy">Stéphane Lehéricy</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D48 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000D48 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:22649063 |texte= Magnetic resonance imaging of the substantia nigra in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22649063" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |